Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 6790

BillFederalHouseIn Committee
New Era of Preventing End-Stage Kidney Disease Act
About This Bill
Committee
Latest Action · December 17, 2024
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
December 14, 2023
Cosponsors (50)
33D 17R
View PDF ↗

Summary

Highlight any text to annotate
This bill aims to prevent end-stage kidney disease by establishing research centers, improving diagnostics, and training healthcare providers to better identify and treat rare kidney diseases. It creates regional Centers of Excellence for Rare Kidney Disease Research through the National Institute of Diabetes and Digestive and Kidney Diseases, funded at six million dollars annually through fiscal year 2028, to conduct research and increase public awareness particularly in rural and underserved communities. The legislation also requires the Secretary of Health and Human Services to conduct a comprehensive study on testing and treatment methods for rare kidney diseases, including genetic testing and diagnostic barriers, with results due within 18 months. Additionally, it funds education programs to train primary care providers and nephrologists about rare kidney disease prevention and diagnosis, with special attention to populations disproportionately affected by these conditions. The bill authorizes one million dollars annually through 2028 for the study and evaluation of treatment methods designed to delay or prevent the need for dialysis and transplants.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.